NCT05388383

Brief Summary

With the change of lifestyle and the aging of the population, the prevalence of Lumbar disc herniation (LDH) in my country is increasing year by year, and surgery is one of the main ways to treat LDH. Surgical robots have good application prospects in the surgical treatment of patients with lumbar degenerative diseases. Studies have shown that orthopedic robot-assisted surgery has less soft tissue damage, small surgical incisions, less bleeding, high safety, and quick postoperative recovery; it reduces the risk of spinal cord and blood vessel damage that may be caused during manual operations; does not require repeated fluoroscopy To determine the position of the nail, reduce the intraoperative radiation by more than 70%, and reduce the risk of patient infection. The current clinical research on robotics technology mainly stays in the aspects of accuracy, effectiveness, and safety. If the technology is promoted in clinical applications, the support of health economics evaluation data is urgently needed. This study hopes to apply robot-assisted technology in LDH surgical treatment through observational research design, evaluate the therapeutic effect and treatment cost of robot-assisted surgery and conventional surgery, focus on health economics evaluation, and provide treatment options for patients and medical care in the health sector. The reasonable allocation of resources and the promotion and application of this technology provide data support.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2021

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

May 24, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

7 months

First QC Date

January 14, 2021

Last Update Submit

May 23, 2022

Conditions

Keywords

robot-assistedspine surgerycost-effectiveness

Outcome Measures

Primary Outcomes (5)

  • COST

    Perioperative cost

    Up to 12 months

  • Visual Analogue Scale

    The basic method is to use a moving ruler with a length of about 10cm. One side is marked with 10 scales. The two ends are respectively "0" and "10" points. A point of 0 means no pain, and a point of 10 means the most intolerable Severe pain.

    Up to 12 months

  • Oswestry Disability Index

    The minimum score for each item is 0 points, and the highest score is 5 points. The higher the score, the more severe the degree of dysfunction; the corresponding scores of the 10 items are accumulated. Calculate the percentage of the highest score (50 points) of the 10 items, which is the Oswestry dysfunction index. The higher the score, the more severe the patient's dysfunction.

    Up to 12 months

  • modified Japanese orthopaedic association score

    Spinal function scoring method, including limb movement, sensory and bladder function evaluation, a total of 17 points. The higher the score, the better the recovery of spinal cord function.

    Up to 12 months

  • SF-36(Medical Outcomes Study Short-Form 36)

    Medical Outcomes Study S hort-Form 36. There are 8 dimensions to evaluate health-related life quality (HRQOL), which are divided into two categories: physical health and physical health, namely physical function (PF), physical function (RP), physical pain (BP), General health (CH), vitality (VT), social function (SF), emotional function (RE), mental health (MH). The score is between 0-100, a high score indicates a good health.

    Up to 12 months

Secondary Outcomes (6)

  • operation time

    During surgery

  • blood lose

    During surgery

  • Radiation dose

    During surgery

  • Complications

    immediately after the surgery, up to 12 weeks

  • Hospital stay

    days between in and out hospital

  • +1 more secondary outcomes

Study Arms (3)

free-hand

spine surgery without robot

robot-assisted

Robot-assisted open surgery

Device: Ti-robot

mi

Robot-assisted minimally invasive surgery

Device: Ti-robot

Interventions

Ti-robotDEVICE

Tianji ROBOT--Orthopedic surgery robot led by Beijing Jishuitan Hospital

mirobot-assisted

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who come to our hospital and meet the inclusion and exclusion criteria

You may qualify if:

  • Diagnose lumbar degenerative diseases and lumbar fractures
  • single-level lumbar pedicle screw internal fixation
  • Sign informed consent

You may not qualify if:

  • Multi-level lumbar pedicle screw internal fixation
  • QCT diagnoses severe osteoporosis (BMD \<60mg/cm3).
  • Combined with abnormal coagulation function
  • Combined with serious medical diseases
  • Spinal cord injury, paraplegia
  • The doctor or nurse believes that it is not appropriate to enroll patients (such as unable to cooperate in completing the study, unable to communicate effectively, severe mental anxiety, lower limb movement disorders, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Jishuitan hospital

Beijing, Beijing Municipality, 100000, China

Location

Study Officials

  • tian wei, MD,PHD

    Beijing Jishuitan Hospital

    STUDY CHAIR

Central Study Contacts

mingxing fan, MD,PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Head of Spine department, Principal Investigator

Study Record Dates

First Submitted

January 14, 2021

First Posted

May 24, 2022

Study Start

June 1, 2022

Primary Completion

January 1, 2023

Study Completion

January 1, 2025

Last Updated

May 24, 2022

Record last verified: 2022-05

Locations